Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that leading French biopharmaceutical company Laboratoires Servier has selected Genedata Screener® as part of its drug discovery research computational platform.
Servier chose Genedata Screener to establish a unified and universal data analysis system to extract insights from data from multiple sources, stored in various locations. The company will use Genedata Screener to significantly increase the speed and decrease the cost of medium- to high-throughput experiments employing complex technologies such as high-content screening and biophysical screening, including surface plasmon resonance, bio-layer interferometry, and thermal shift analysis, among others.
Genedata Screener federates data from in vitro screening assays, harmonizing and integrating all analysis workflows at Servier into one platform. To further boost Servier’s research efficiency, Genedata Screener will also integrate with instruments from manufacturers and data from contract research organizations that partner with the company. All elements of the platform are expected to be operational in 2020.
“Servier was looking at consolidating in vitro assay data analysis in a single state-of-the-art application explained Jean-Philippe Stephan, Ph.D., Director, Center of Excellence Pharmacological Screening, Compound Management and Biobanking at Laboratoires Servier. “After reviewing the options available to us, we concluded that Genedata Screener matches perfectly with our vision of being totally compatible with other digital innovation initiatives currently ongoing at Servier. Through the deployment of open and intuitive tools, our objective is truly to enable our collaborators to capitalize on all R&D data, interconnecting and federating multiple expert solutions to further optimize our innovation capabilities to better address patients’ unmet medical needs.”
Othmar Pfannes, Ph.D., CEO of Genedata, added, “We are honored to be selected by Servier as the ideal partner for its ambitious digital transformation project. Genedata Screener, a component of the Genedata Biopharma Platform—an interconnected suite of several Genedata systems that can be used stand-alone, or in combination to provide a fully integrated solution for biopharma R&D—is ideally suited to facilitate the company’s aims of establishing a world-leading R&D center with the ability to fully engage with data from any location in the world, to rapidly derive valuable scientific and business insights.”